Market Movers

Albemarle Corporation’s Stock Price Dips to $99.38, Marking a 3.42% Decline: A Comprehensive Overview

By December 14, 2024 No Comments

Albemarle Corporation (ALB)

99.38 USD -3.52 (-3.42%) Volume: 1.64M

Albemarle Corporation’s stock price currently stands at 99.38 USD, witnessing a drop of 3.42% in today’s trading session with a trading volume of 1.64M, reflecting a significant YTD decline of 31.22%, shedding light on its turbulent market performance.


Latest developments on Albemarle Corporation

Albemarle Corp. has been making headlines recently, with the announcement of their new lithium hydroxide battery material plant earning them the title of Best Project in the Power/Industrial sector. This recognition, along with being named one of the World’s Best Companies by TIME Magazine, has boosted investor confidence in the company. Despite underperforming compared to competitors on Tuesday, Albemarle’s stock managed to outperform them overall, even announcing a quarterly common stock dividend. Investors will be keeping a close eye on the company’s performance, especially after their participation in the Deutsche Bank 9th Annual Lithium & Battery Supply Chain Conference.


Albemarle Corporation on Smartkarma

Analysts at Baptista Research have been closely monitoring Albemarle Corp‘s performance and have published two research reports on Smartkarma. In their report titled “Albemarle Corporation: Will Its Volume Growth & Asset Utilization Help Bring A Shift In The Competitive Dynamics? – Major Drivers,” they highlight the company’s strong Q3 2024 earnings, with volumetric growth in the Energy Storage division and year-over-year EBITDA growth in other segments. The report also mentions Albemarle’s strong liquidity and leverage metrics, with the company maintaining leverage below covenant limits and demonstrating strong operating cash conversion. Baptista Research aims to evaluate various factors influencing the company’s stock price and conduct an independent valuation using a Discounted Cash Flow methodology.

Another report by Baptista Research, titled “Albemarle Corporation: These Are The 7 Factors Driving Our ‘Buy’ Rating! – Financial Forecasts,” discusses Albemarle Corp‘s Q2 2024 earnings, which showed a mix of operational successes and challenges in line with the industry landscape. The company reported a decrease in net sales to $1.4 billion from $2.4 billion the previous year, primarily due to decreased pricing. Albemarle also experienced a significant downturn in profitability, with a loss of $188 million and a diluted loss per share of $1.96. Despite these challenges, Baptista Research remains bullish on Albemarle Corp, highlighting seven factors that drive their ‘Buy’ rating for the company.


A look at Albemarle Corporation Smart Scores

FactorScoreMagnitude
Value4
Dividend3
Growth2
Resilience4
Momentum5
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Albemarle Corp, a company that specializes in producing specialty and fine chemicals, has been given a positive outlook based on the Smartkarma Smart Scores. With high scores in Value, Resilience, and Momentum, Albemarle Corp is positioned well for long-term success. The company’s strong value and resilience indicate stability and potential for growth, while its momentum suggests positive market sentiment and performance.

Despite lower scores in Growth and Dividend, Albemarle Corp‘s overall outlook remains optimistic. The company’s focus on producing chemicals used in various industries such as plastics, pharmaceuticals, and agriculture, coupled with its majority production in the United States, positions it well for continued success in the future.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars